BNP Paribas Financial Markets
RPTX

BNP Paribas Financial Markets’s Repare Therapeutics RPTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$3 – 6074
2025
Q4 		$3 Hold
1
– – ﹤0.01% 5718
2025
Q3 		$2 Hold
1
– – ﹤0.01% 5546
2025
Q2 		$1 Hold
1
– – ﹤0.01% 5429
2025
Q1 		$1 Hold
1
– – ﹤0.01% 5369
2024
Q4 		$1 Buy
+1
New +$3 ﹤0.01% 5392

BNP Paribas Financial Markets's RPTX Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 1 share — an estimated $3 sold.

BNP Paribas Financial Markets first reported a position in RPTX in Q4 2024 and held it in 5 quarters. The position peaked at $3 in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1 Repare Therapeutics share in Q1 2026, an estimated $3.
  • BNP Paribas Financial Markets first reported a position in Repare Therapeutics in Q4 2024 and held it in 5 quarters.
  • BNP Paribas Financial Markets's Repare Therapeutics position peaked at $3 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.